David Sciberras

2.1k citations

31 papers · 1.5k indexed · h-index 19

Impact in

Parasitology top 2%
- Parasites and Host Interactions
Orthopedics and Sports Medicine top 5%
- Bone health and osteoporosis research
- Bone and Joint Diseases

Papers in ⓘ

Psychiatry and Mental health 8
- Epilepsy research and treatment 5
- Migraine and Headache Studies 3
Applied Microbiology and Biotechnology 1

Co-authors: Arturo G. Porras (3 shared papers)Coleen M. Clineschmidt (2 shared papers)Christine Furtek (2 shared papers)Cong Chen (2 shared papers)Robert Tipping (2 shared papers)Kenneth C. Lasseter (2 shared papers)Cynthia Guzzo (2 shared papers)Michael R. Goldberg (6 shared papers)
Journals: British Journal of Clinical Pharmacology (8 papers)Journal of Bone and Mineral Research (2 papers)The Journal of Clinical Pharmacology (2 papers)EJNMMI Physics (1 paper)Biological Psychiatry (1 paper)
Partner nations: United States United Kingdom Belgium

In The Last Decade

David Sciberras

30 papers receiving 1.4k citations

Peers

Countries citing papers authored by David Sciberras

Since Specialization

Citations

This map shows the geographic impact of David Sciberras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sciberras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sciberras more than expected).

Fields of papers citing papers by David Sciberras

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sciberras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sciberras. The network helps show where David Sciberras may publish in the future.

Co-authors

The 25 scholars most cited alongside David Sciberras, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Sciberras Line = papers co-authored together David Sciberras links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects The Journal of Clinical Pharmacology ·Cynthia Guzzo, Christine Furtek, Arturo G. Porras, Cong Chen, Robert Tipping, Coleen M. Clineschmidt, David Sciberras, John Y‐K. Hsieh, Kenneth C. Lasseter	2002	249
2	Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis Journal of Bone and Mineral Research ·Sohail A. Khan, John А. Kanis, Samuel D Vasikaran, W. F. Kline, B.K. Matuszewski, Eugène McCloskey, M.N.C. Benéton, Barry J. Gertz, David Sciberras, Sherry D. Holland, Jane Orgee, G. Coombes, S. Rogers, Arturo G. Porras	1997	225
3	Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects The Journal of Clinical Pharmacology ·Cynthia Guzzo, Christine Furtek, Arturo G. Porras, Cong Chen, Robert Tipping, Coleen M. Clineschmidt, David Sciberras, John Y.‐K. Hsieh, Kenneth C. Lasseter	2002	215
4	Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant Biological Psychiatry ·Mats Bergström, Richard Hargreaves, H. Donald Burns, Michael R. Goldberg, David Sciberras, Scott A. Reines, Kevin J. Petty, Mattias Ögren, Gunnar Antoni, Bengt Långström, Olli Eskola, Mika Scheinin, Olof Solin, Anup Majumdar, M.L. Constanzer, Wendy P. Battisti, Thomas E. Bradstreet, Cynthia Gargano, Jarmo Hietala	2004	152
5	Comparison of Angiotensin-Converting Enzyme Inhibition with Angiotensin II Receptor Antagonism in the Human Forearm Journal of Cardiovascular Pharmacology ·John R. Cockcroft, David Sciberras, Michael R. Goldberg, James M. Ritter	1993	79
6	Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue European Journal of Nuclear Medicine and Molecular Imaging ·Michel Koole, June van Aalst, Martijn Devrome, Nathalie Mertens, Kim Serdons, Brigitte Lacroix, Joël Mercier, David Sciberras, R. P. Maguire, Koen Van Laere	2018	72
7	Initial human experience with MK‐462 (rizatriptan): a novel 5=HT_ID agonist British Journal of Clinical Pharmacology ·David Sciberras, William J. Polvino, Barry J. Gertz, Haiyung Cheng, Michael Stepanavage, Johanna Wittreich, Timothy Olah, Mark Edwards, Timothy Mant	1997	43
8	Pharmacokinetics of Total and Unbound Ertapenem in Healthy Elderly Subjects Antimicrobial Agents and Chemotherapy ·Donald G. Musson, Anup Majumdar, Steven M. Holland, Kimberly L Birk, Liwen Xi, Goutam C. Mistry, David Sciberras, J. Muckow, Paul Deutsch, John Rogers	2004	38
9	Influence of β‐adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5‐HT_1B/1D agonist: differential effects of propranolol, nadolol and metoprolol British Journal of Clinical Pharmacology ·Michael R. Goldberg, David Sciberras, Marina De Smet, Richard Lowry, Lisa Tomasko, Yih Lee, Timothy Olah, Jamie J. Zhao, Kamlesh P. Vyas, Rita A. Halpin, Prasad H. Kari, Ian James	2001	37
10	Intra‐arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability British Journal of Clinical Pharmacology ·David E. Newby, David Sciberras, Carl M. Mendel, Barry J. Gertz, Nicholas A. Boon, David J. Webb	1997	35
11	Effects of five daily 1 h infusions of alendronate in paget's disease of bone Journal of Bone and Mineral Research ·D.P. O’Doherty, B. J. Gertz, W. B. Tindale, David Sciberras, Tracy T. Survill, John А. Kanis	1992	34
12	Substance P‐induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in man British Journal of Clinical Pharmacology ·David E. Newby, David Sciberras, Charles J. Ferro, Barry J. Gertz, David Sommerville, Anup Majumdar, Richard C. Lowry, David J. Webb	1999	31
13	Initial human experience with MK-462 (rizatriptan): a novel 5=HT_IDagonist British Journal of Clinical Pharmacology ·David Sciberras, William J. Polvino, Barry J. Gertz, Haiyung Cheng, Michael Stepanavage, Johanna Wittreich, Timothy Olah, Mark Edwards, Timothy Mant	1997	28
14	L-692,429, a nonpeptide growth hormone (GH) secretagogue, reverses glucocorticoid suppression of GH secretion. The Journal of Clinical Endocrinology & Metabolism ·B. J. Gertz, David Sciberras, L. Yogendran, Katherine Christie, KM Bador, David Krupa, Johanna Wittreich, Ian James	1994	27
15	Validation of Parametric Methods for [11C]UCB-J PET Imaging Using Subcortical White Matter as Reference Tissue Molecular Imaging and Biology ·Nathalie Mertens, R. P. Maguire, Kim Serdons, Brigitte Lacroix, Joël Mercier, David Sciberras, Koen Van Laere, Michel Koole	2019	25
16	Radiprodil, a NR2B negative allosteric modulator, from bench to bedside in infantile spasm syndrome Annals of Clinical and Translational Neurology ·Stéphane Auvin, Blandine Dozières‐Puyravel, Andreja Avberšek, David Sciberras, Jo Collier, Karine Leclercq, Pavel Mareš, Rafal M. Kaminski, Pierandrea Muglia	2020	25
17	PHARMACOKINETICS AND FOOD INTERACTION OF MK-462 IN HEALTHY MALES Biopharmaceutics & Drug Disposition ·HAIYUNG CHENG, William J. Polvino, David Sciberras, L. Yogendran, K. Cerchio, Karen Christie, Timothy Olah, Declan M. McLoughlin, Ian James, John Rogers	1996	22
18	Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects Arthritis Research & Therapy ·Jason M. Gow, Wayne Tsuji, Gary J. Williams, Daniel T. Mytych, David Sciberras, Shawn Searle, Tim Mant, John P. Gibbs	2015	22
19	A pharmacokinetic study of radiprodil oral suspension in healthy adults comparing conventional venous blood sampling with two microsampling techniques Pharmacology Research & Perspectives ·David Sciberras, Christian Otoul, Françoise Lurquin, John Smeraglia, Aurélia Lappert, Steven De Bruyn, Jan Jaap van Lier	2019	21
20	Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach Brain Communications ·Pierandrea Muglia, Jonas Hannestad, Christian Brandt, Steven DeBruyn, Massimiliano Germani, Brigitte Lacroix, Marian Majoie, Christian Otoul, David Sciberras, Bernhard J. Steinhoff, Koen Van Laere, Wim Van Paesschen, Elizabeth Webster, Rafal M. Kaminski, Konrad J. Werhahn, Manuel Toledo	2020	18

About David Sciberras

David Sciberras is a scholar working on Psychiatry and Mental health, Applied Microbiology and Biotechnology, Cellular and Molecular Neuroscience, Orthopedics and Sports Medicine and Pediatrics, Perinatology and Child Health, having authored 31 papers that have together received 1.5k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (6 papers), Epilepsy research and treatment (5 papers), Pharmaceutical studies and practices (4 papers), Medical Imaging Techniques and Applications (3 papers), Migraine and Headache Studies (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Receptor Mechanisms and Signaling (3 papers) and Bone health and treatments (3 papers). The work is most often cited by research in Parasitology (202 citations), Orthopedics and Sports Medicine (196 citations), Infectious Diseases (331 citations), Small Animals (129 citations) and Applied Microbiology and Biotechnology (32 citations). David Sciberras has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Arturo G. Porras, Coleen M. Clineschmidt, Christine Furtek, Cong Chen, Robert Tipping, Kenneth C. Lasseter, Cynthia Guzzo, Michael R. Goldberg, Barry J. Gertz and John Y‐K. Hsieh. Their work appears in journals such as British Journal of Clinical Pharmacology, Journal of Bone and Mineral Research, The Journal of Clinical Pharmacology, EJNMMI Physics and Biological Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact